Genmab — Juli 2018

[E_L]

this atezolizumab for MM trial was also updated https://clinicaltrials.gov/ct2/history/NCT02431208?A=39&B=40&C=merged

[E_L]

they also added 1 arm, which inlcudes Dara

[Bulder]

You already posted that last friday

[MarsFars]

Agurketid

[E_L]

ah sorry, i thought i posted the NSCLC last Friday, thx
https://clinicaltrials.gov/ct2/history/NCT03023423?A=20&B=21&C=merged

[E_L]

i do remember also writing something like, there are more updates, but even during Agurketid nobody could be bothered to check lol

[E_L]

Lonial Lays Out Optimal Sequence Strategies for Relapsed/Refractory Myeloma https://www.onclive.com/conference-coverage/pplc-2018/lonial-lays-out-optimal-sequence-strategies-for-relapsedrefractory-myeloma

[E_L]

Revolutionizing MM treatment with daratumumab http://www.oncologytube.com/video/revolutionizing-mm-treatment-with-daratumumab/10004677

[E_L]

this one I think we have seen, but since it is Agurketid Subcutaneous daratumumab: an update on the latest MM clinical trials http://www.oncologytube.com/video/subcutaneous-daratumumab-an-update-on-the-latest-mm-clinical-trials/10004685

[transalp]

De tåler gentagelser..

[Legolas23]

Svært at sige, men din tanke vækker undren og eftertanke.

[Plimsoller]

God morgen

[Plimsoller]

[transalp]

Go morgen

[polle1]

God morgen

[JørgenVarnæs]

Godmorgen. Har nogen set recepttallene i dag?

[Helge_LarsenPI-redaktør]

Desværre ikke her.

[JørgenVarnæs]

Ærgerligt. Hvis du ser dem, må du meget gerne poste dem Helge. Det ser ud til, at der sker noget i pris/mængde mixet i disse måneder

[Helge_LarsenPI-redaktør]

Jeps...

[fillipa]

Genmab (hold) – Det amerikanske Darzalex-salg er blevet offentliggjort af Symphony Health Solutions, og det lander på 116,1 mio. dollar i juni, ned knap 5 % fra 122 mio. dollar i maj. På daglig basis falder salget 0,3 % siden maj. Johnson & Johnson offentliggjorde allerede i sidste uge salgstallene for andet kvartal, hvorfor det ikke er en overraskelse, at det daglige salg falder en smule i juni sammenlignet med maj. Vi fastholder vores tidligere prognose. Fremskriver vi væksten fra Q2, lander D